NuPathe Inc., of Conshohocken, Pa., appointed Keith A. Goldan vice president and chief financial officer...PDL BioPharma Inc., of Redwood City, Calif., elected Paul W. Sandman and John P. McLaughlin to its board...Potential Pharmaceuticals, of Louisville, Ky., appointed Johanna M. Seddon and Janet Stoltz Sunness to its scientific advisory board

ImmunoGen Inc., of Waltham, Mass., appointed James J. O'Leary vice president and chief medical officer...Infinity Pharmaceuticals Inc., of Cambridge, Mass., promoted Adelene Q. Perkins president and chief business officer...It also appointed Bruce R. Thaw chairman and named James E. Rothman chairman of the scientific advisory board

Bioheart Inc., of Sunrise, Fla., appointed Matt Fendrich vice president of sales and marketing and named Alan P. Timmins to the board...Biovail Corp., of Toronto, appointed H. Christian Fibiger senior vice president and chief scientific officer of Biovail Laboratories International SRL...BioXcel Corp., of New Haven, Conn., added R. Christopher Seaton, Martha Matteo and Kevin Rakin to its corporate advisory board

AAIPharma, of Wilmington, N.C., appointed Andreas Dreps senior vice president of global clinical development services and named Ralf Wolter vice president of clinical operations, Europe...Adimab Inc., of Lebanon, N.H., appointed Guy Van Meter senior director and head of business development...Antisoma plc, of London, appointed Eric Dodd chief financial officer and board member

UCB SA, of Brussels, Belgium, appointed Michele Antonelli executive vice president of technical operations and quality assurance and named Mark McDade executive vice president of global operations

It also named Chas Bountra as chairman and Annette Dolphin to its scientific advisory board...and Faith Pomeroy-Ward as executive director of investor relations and corporate communications

Prometheus Laboratories Inc., of San Diego, named Mark Spring senior vice president and chief financial officer...Targanta Therapeutics Corp., of Cambridge, Mass., appointed Stéphane Bancel and Rosemary A. Crane to its board...Trubion Pharmaceuticals Inc., of Seattle, appointed Scott C. Stromatt senior vice president and chief medical officer

Arcxis Biotechnologies, of Pleasanton, Calif., named Christine Meda president and CEO...Calibrant Biosystems, of Gaithersburg, Md., appointed James Hawkins, Bethany Mancilla and Douglas Swirsky to its business advisory board...Lipoxen plc, of London, promoted Peter Laing to chief operating officer and appointed Ajay K. Agrawal head of business development

PolyMedix Inc., of Radnor, Pa., elected Richard Bank and Stefan Loren to its board...PPD Inc., of Wilmington, N.C., appointed Christine Dingivan executive vice president and chief medical officer

GenVault Corp., of Carlsbad, Calif., named Myla P. Lai-Goldman and Jack Ballantyne to its scientific advisory board...Illumina Inc., of San Diego, appointed Mostafa Ronaghi senior vice president and chief technology officer...MediGene AG, of Martinsried, Germany, said Thomas Strüngmann and Mathias Albert Boehringer were elected as new supervisory board members

Alpharma Inc., of Bridgewater, N.J., appointed Ron Warner executive vice president and chief scientific officer and named R. Scott Shively senior vice president of pharmaceutical commercial operations...Althea Technologies Inc., of San Diego, named E. J. Brandreth vice president of quality and regulatory

Javelin Pharmaceuticals Inc., of Cambridge, Mass., named Daniel Carr president and said Fred Mermelstein assumed the role of executive director...Oncothyreon Inc., of Bellevue, Wash., named Daniel K. Spiegelman and Stephen K. Burley to its board...Pantec Biosolutions AG, of Ruggell, Leichtenstein, appointed Burkhard Feurstein and Michael Armbruester to its board

Adolor Corp., of Exton, Pa., promoted Lee Techner to vice president of medical affairs and medical director...It also named Guido Magni to its board and the governance and nominating committee

VirtualHealth Technologies Inc., of Lexington, Ky., named Robert Tapales vice president of operations. Westfield Capital Management, of Boston, named Lawrence C. Fritz Life Sciences Venture Partner. WuXi PharmaTech, of Shanghai, China, appointed Peng Wang vice president of discovery biology. XTL Biopharmaceuticals Ltd., of Valley College, N.Y., appointed Laurence N. Charney to its board.

Stem Cell Therapeutics Corp., of Calgary, Alberta, named Thomas Franck vice president of commercial planning. Trius Therapeutics Inc., of San Diego, appointed Paul Truex to its board. VentiRx Pharmaceuticals Inc., of San Diego, named Elliott Grossbard to its board.

Premier Research Group plc, of Philadelphia, appointed Anthony Faragasso, executive director and global head of medical management and safety...Somnus Therapeutics Inc., of Bedminster, N.J., named Gary Cupit, Mary Osbakken, Christine Blumhardt, Linda Hogan and Anne McCormick to its executive development team

Altus Pharmaceuticals Inc., of Cambridge, Mass., appointed Georges Gemayel, CEO and member of the board...Ariad Pharmaceuticals Inc., of Cambridge, Mass., appointed Raymond T. Keane vice president, general counsel and chief compliance officer...Endo Pharmaceuticals Holdings Inc., of Chadds Ford, Pa., named Blaine T. Davis vice president of investor relations and corporate communications

Sigma-Aldrich, of St. Louis, said Chief Administrative Officer and Chief Financial Officer Michael R. Hogan will retire this summer...He will become an unpaid vice president and outside director of the Sigma-Aldrich Foundation...Vyteris Inc., of Fair Lawn, N.J., appointed Haro Hartounian president and Joseph Himy chief financial officer

Dyax Corp., of Cambridge, Mass., named Mark J. Sawyer as senior vice president of process sciences and technical operations